ENABLING NEW CAPABILITIES IN PATIENT-CENTRIC THERAPY
Using an aqueous fluid to bind together multiple layers of powder, our unique, patent-protected 3DP technology platform can be used to solve some of your toughest therapeutic challenges across multiple therapeutic areas.
HIGHER DOSE LOADS
Support dose loading up to 1,000 mg
Rapidly disintegrates on contact with liquid by breaking the bonds created during the 3DP process
Allows the application of enhanced taste-masking techniques
Because of its unique digitally coded layering and zero-compression processes, ZipDose Technology can hold a high dosage load and still maintain rapid disintegration with just sip of water. ZipDose Technology can offer patients with swallowing difficulty or high pill burden an easier way to take medicine.
Extend product lines and market share with broader patient reach and/or continued brand exclusivity via 505(B)(2) submissions of patent-protected ZipDose formulations.
With multiple patient, manufacturing, regulatory and business benefits, ZipDose opens new opportunities in multiple therapeutic areas, bringing significant advantages to your pipeline.
Patients and caregivers can experience a rapidly disintegrating, taste-masked, and convenient way to take or administer medicine, while providers can prescribe high-dose formulations for patients with swallowing issues or burdensome dosing regimens.
MEET SPRITAM, THE FIRST 3D PRINTED DRUG APPROVED BY FDA
Manufactured with Aprecia’s ZipDose 3DP technology, Spritam (levetiracetam) is available in 4 dose strengths, up to 1,000 mg, and provides appropriate patients who may have difficulty swallowing large tablets an option for an advanced fast-melt tablet. Spritam is the first 3D printed drug approved by the FDA and is currently available by prescription only.
LAYERS AND LAYERS OF PRECISION
Combining the precision of 3D printing and formulation science, ZipDose Technology produces rapidly disintegrating formulations of medications even at high dose loads of up to 1,000 mg.